The GL261 glioma cell line and activation of TLR2 upregulated the expression of MMP2 and MMP9 to promote tumor invasion, indicating that TLR2 signaling in glioblastoma stem cells (GSCs) is involved in the invasiveness of glioma. Here, MMP9 is linked to central nervous system cancer.